Anti-interferon therapy for systemic lupus erythematosus

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To determine the benefits and harms of anti-interferon therapy in the management of systemic lupus erythematosus (SLE).

This is a protocol.

Health topics:

Rheumatology > Lupus erythematosus

Published:

13 July 2022

Authors:

Ventura MJ, Bruera S, Suarez-Almazor ME, Agarwal SK, Krause K, Lopez-Olivo MA

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ventura MJ, Bruera S, Suarez-Almazor ME, Agarwal SK, Krause K, Lopez-Olivo MA. Anti-interferon therapy for systemic lupus erythematosus (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 7. Art. No.: CD014723. DOI: 10.1002/14651858.CD014723.